Skip to content

Tamiflu prescribing by doctors in hospitals

Neuraminidase inhibitor prescribing by physicians in the UK: a questionnaire-based survey of practice

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN18249297
Enrollment
1000
Registered
2015-10-29
Start date
2015-10-01
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza Infections and Infestations

Interventions

The basis of this study is a online survey developed to explore current UK physician knowledge of existing neuraminidase inhibitor prescribing guidelines and self-reported prescribing practice for adu
La Jolla, California) and SPSS (SPSS, Inc
Chicago, Illinois) will be used for statistical analysis. Demographic details (including place of work, speciality and seniority), influenza testing method and guideline awareness will be described us

Sponsors

University Hospitals Southampton Foundation NHS trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. A hospital-based physician (consultant or specialist registrar grade or equivalent) 2. Working in the UK and managing patient with suspected influenza 3. Working in infectious diseases, microbiology, respiratory medicine, acute medicine, emergency medicine or geriatric medicine

Exclusion criteria

Exclusion criteria: Not meeting any of the inclusion criteria

Design outcomes

Primary

MeasureTime frame
Self reported neuraminidase inhibitor prescribing practice and adherence to National guidelines. Collected and analysed one month after last surveys have been sent out.

Secondary

MeasureTime frame
Differences in practice between specialities. Collected and analysed one month after last surveys have been sent out.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026